ClinicalTrials.Veeva

Menu

Investigating STAT3 as a Driver of Pathology in Periodontitis

U

University of Chile

Status

Completed

Conditions

Periodontitis

Treatments

Other: no intervention

Study type

Observational

Funder types

Other

Identifiers

NCT05506098
11180389
FONDECYT 11180389 (Other Grant/Funding Number)

Details and patient eligibility

About

Periodontitis is a prevalent inflammatory condition that destroys tooth-supporting structures. This condition is associated with pro-inflammatory mediators that utilize STAT3 as an activator of specific genes related to inflammation and tissue destruction. STAT3 has not been studied in the context of periodontitis in humans. We propose that STAT3 is associated with periodontitis. This knowledge might help to further our understanding of periodontitis pathology

Enrollment

28 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18-year-old, in good general health, and had no significant medical history.
  • no history of diabetes or other diseases different than periodontitis.

Exclusion criteria

  • Pregnancy and lactation
  • Use of antibiotics, immunosuppressive agents, or probiotics within 3 months.

Trial design

28 participants in 2 patient groups

Healthy
Description:
Subjects without periodontitis
Treatment:
Other: no intervention
Periodontitis
Description:
Subjects with periodontitis
Treatment:
Other: no intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems